SEC Form 4 · accession 0001144204-15-062177
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent Capponi
Officer — Chief Operating Officer
Period of report
Oct 29, 2015
Accepted (ET)
Nov 2, 2015 · 3:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 29, 2015 | M | 4,000 | $0.875 | A | 20,724 | D | |
| Common Stock | Oct 29, 2015 | S | 4,000 | $7.50 | D | 16,724 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $0.875 | Oct 29, 2015 | M | 4,000 | D | — | Jun 25, 2018 | Common Stock | 4,000 | 76,000 | D |
Explanation of responses
- F1Stock option exercise and open market sale conducted pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2This option vested and became exercisable as to 25% of the shares on each of June 25, 2008, June 25, 2009, June 25, 2010 and June 25, 2011.